AIM
AMPH icon

Assured Investment Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Assured Investment Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,661
Closed -$34K – 83
2019
Q1 		$34K Sell
1,661
-12,161
-88% -$272K ﹤0.01% 997
2018
Q4 		$275K Sell
13,822
-3,392
-20% -$66.9K 0.01% 820
2018
Q3 		$331K Sell
17,214
-9,145
-35% -$163K 0.01% 881
2018
Q2 		$402K Sell
26,359
-15,940
-38% -$279K 0.01% 870
2018
Q1 		$793K Buy
+42,299
New +$795K 0.02% 623

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Assured Investment Management's AMPH Position: Q2 2019 in Review

Assured Investment Management sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2019, closing a stake of 1,661 shares — an estimated $34K sold.

Assured Investment Management first reported a position in AMPH in Q1 2018 and held it in 5 quarters. The position peaked at $793K in Q1 2018. 133 funds tracked by Wall St. Rank hold AMPH as of Q2 2019.

  • Assured Investment Management reported no remaining Amphastar Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Assured Investment Management sold 1,661 Amphastar Pharmaceuticals shares in Q2 2019, an estimated $34K.
  • Assured Investment Management first reported a position in Amphastar Pharmaceuticals in Q1 2018 and held it in 5 quarters.
  • Assured Investment Management's Amphastar Pharmaceuticals position peaked at $793K in Q1 2018.
  • 133 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.